Delaware | 95-3359658 | ||||||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||||||||
One Park Place, | Suite 600 | ||||||||||
Dublin, | CA | 94568 | |||||||||
(Address of principal executive offices) | (Zip Code) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Common stock par value $0.000025 per share | TNET | New York Stock Exchange |
Large accelerated filer | x | Accelerated filer | o | ||||||||
Non-accelerated filer | o | Smaller reporting company | ☐ | ||||||||
Emerging growth company | ☐ |
TABLE OF CONTENTS |
Form 10-Q Cross Reference | Page | |||||||
Part I, Item 1. | ||||||||
Part I, Item 2. | ||||||||
Part I, Item 3. | ||||||||
Part I, Item 4. | ||||||||
Part II, Item 1. | ||||||||
Part II, Item 1A. | ||||||||
Part II, Item 2. | ||||||||
Part II, Item 3. | ||||||||
Part II, Item 4. | ||||||||
Part II, Item 5. | ||||||||
Part II, Item 6. | ||||||||
TRINET | 2 | 2023 Q3 FORM 10-Q |
GLOSSARY |
2021 Credits | Our announced 2021 credits, which provided eligible clients with discretionary credits, subject to certain predefined conditions. | ||||
2022 Credits | Includes both of our announced 2022 credits, each of which provides eligible clients with discretionary credits, subject to certain predefined conditions. | ||||
2021 Credit Agreement | Our credit agreement dated February 26, 2021, as amended, supplemented or modified from time to time, most recently August 16, 2023. | ||||
2021 Revolver | Our $700 million revolving line of credit included in our 2021 Credit Agreement | ||||
2029 Notes | Our $500 million senior unsecured notes maturing in March 2029 | ||||
2031 Notes | Our $400 million senior unsecured notes maturing in August 2031 | ||||
AFS | Available-for-sale | ||||
CARES Act | Coronavirus Aid Relief and Economic Security Act | ||||
CEO | Chief Executive Officer | ||||
CFO | Chief Financial Officer | ||||
Clarus R+D | Clarus R+D Solutions, LLC | ||||
COBRA | Consolidated Omnibus Budget Reconciliation Act | ||||
Colleague | TriNet’s internal employees (as distinguished from WSEs and HRIS Users) | ||||
COPS | Cost of providing services | ||||
COVID-19 | Novel coronavirus | ||||
D&A | Depreciation and amortization expenses | ||||
EBITDA | Earnings before interest expense, taxes, depreciation and amortization of intangible assets | ||||
EPS | Earnings Per Share | ||||
ERISA | Employee Retirement Income Security Act | ||||
ESAC | Employer Services Assurance Corporation | ||||
ETR | Effective tax rate | ||||
FFCRA | Families First Coronavirus Response Act | ||||
G&A | General and administrative | ||||
GAAP | Generally Accepted Accounting Principles in the United States | ||||
HCM | Human capital management | ||||
HR | Human Resources | ||||
HRIS | Human resources information system | ||||
HRIS User | A client employee who is not co-employed by a TriNet PEO (for example, employees of a TriNet Zenefits client) | ||||
IRS | Internal Revenue Service | ||||
ICR | Insurance cost ratio | ||||
ISR | Insurance service revenues | ||||
LIBOR | London Inter-bank Offered Rate | ||||
MD&A | Management's Discussion and Analysis of Financial Condition and Results of Operations | ||||
OE | Operating expenses | ||||
PEO | Professional Employer Organization | ||||
PFC | Payroll funds collected | ||||
PPP | Paycheck Protection Program, a loan program administered by the U.S. Small Business Administration | ||||
PSR | Professional service revenues | ||||
R+D | Research and Development | ||||
Recovery Credit | Our 2020 Recovery Credit to provide eligible clients with one-time reductions against fees for future services | ||||
Recovery Credits | Collectively, our Recovery Credit, 2021 Credits, and 2022 Credits | ||||
Reg FD | Regulation Fair Disclosure | ||||
ROU | Right-of-use | ||||
RSA | Restricted Stock Award | ||||
RSU | Restricted Stock Unit | ||||
TRINET | 3 | 2023 Q3 FORM 10-Q |
GLOSSARY |
SBC | Stock Based Compensation | ||||
S&M | Sales and marketing | ||||
S&P | Standard & Poor's | ||||
SD&P | Systems development and programming | ||||
SEC | U.S. Securities and Exchange Commission | ||||
SMB | Small and medium-size business | ||||
U.S. | United States | ||||
WSE | A worksite employee who is co-employed by, or otherwise receiving services from a TriNet PEO | ||||
YTD | Year to date | ||||
Zenefits | YourPeople, Inc. (dba Zenefits) and its subsidiaries |
TRINET | 4 | 2023 Q3 FORM 10-Q |
FORWARD LOOKING STATEMENTS AND OTHER FINANCIAL INFORMATION |
TRINET | 5 | 2023 Q3 FORM 10-Q |
FORWARD LOOKING STATEMENTS AND OTHER FINANCIAL INFORMATION |
TRINET | 6 | 2023 Q3 FORM 10-Q |
MANAGEMENT'S DISCUSSION AND ANALYSIS |
TRINET | 7 | 2023 Q3 FORM 10-Q |
MANAGEMENT'S DISCUSSION AND ANALYSIS |
$1.2B | $116M | 84% | ||||||||||||||||||||||||
Total revenues | Operating income | Insurance cost ratio | ||||||||||||||||||||||||
(2) | % | decrease | (3) | % | decrease | 1 | % | increase | ||||||||||||||||||
$94M | $1.63 | $109M | ||||||||||||||||||||||||
Net income | Diluted EPS | Adjusted Net income * | ||||||||||||||||||||||||
22 | % | increase | 33 | % | increase | 5 | % | increase | ||||||||||||||||||
333,286 | 335,741 | 210,863 | ||||||||||||||||||||||||
Average WSEs ** | Total WSEs ** | Average HRIS Users | ||||||||||||||||||||||||
(5) | % | decrease | (5) | % | decrease | (15) | % | decrease | ||||||||||||||||||
* | ||||||||||||||||||||||||||
** | Total WSEs includes approximately 4,600 additional service recipients and Average WSEs includes approximately 1,500 additional service recipients, in each case identified as a result of our ongoing effort to ensure that our billing practices best match the expectations of our customers. For details, refer to the heading "Operating Metrics – Worksite Employees (WSEs).” |
$3.7B | $382M | 83% | ||||||||||||||||||||||||
Total revenues | Operating income | Insurance cost ratio | ||||||||||||||||||||||||
— | % | flat | (14) | % | decrease | 1 | % | increase | ||||||||||||||||||
$308M | $5.20 | $365M | ||||||||||||||||||||||||
Net income | Diluted EPS | Adjusted Net income * | ||||||||||||||||||||||||
— | % | flat | 8 | % | increase | (3) | % | decrease | ||||||||||||||||||
329,257 | 335,741 | 219,058 | ||||||||||||||||||||||||
Average WSEs ** | Total WSEs ** | Average HRIS Users | ||||||||||||||||||||||||
(6) | % | decrease | (5) | % | decrease | (13) | % | decrease | ||||||||||||||||||
* | ||||||||||||||||||||||||||
** | Total WSEs includes approximately 4,600 additional service recipients and Average WSEs includes approximately 1,500 additional service recipients, in each case identified as a result of our ongoing effort to ensure that our billing practices best match the expectations of our customers. For details, refer to the heading "Operating Metrics – Worksite Employees (WSEs).” |
TRINET | 8 | 2023 Q3 FORM 10-Q |
MANAGEMENT'S DISCUSSION AND ANALYSIS |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
(in millions, except operating metrics data) | 2023 | 2022 | % Change | 2023 | 2022 | % Change | |||||||||||||||||
Income Statement Data: | |||||||||||||||||||||||
Professional service revenues | $ | 185 | $ | 189 | (2) | % | $ | 567 | $ | 565 | — | % | |||||||||||
Insurance service revenues | 1,037 | 1,052 | (1) | 3,110 | 3,094 | 1 | |||||||||||||||||
Total revenues | 1,222 | 1,241 | (2) | 3,677 | 3,659 | — | |||||||||||||||||
Insurance costs | 874 | 872 | — | 2,594 | 2,547 | 2 | |||||||||||||||||
Operating expenses | 232 | 249 | (7) | 701 | 669 | 5 | |||||||||||||||||
Total costs and operating expenses | 1,106 | 1,121 | (1) | 3,295 | 3,216 | 2 | |||||||||||||||||
Operating income | 116 | 120 | (3) | 382 | 443 | (14) | |||||||||||||||||
Other income (expense): | |||||||||||||||||||||||
Interest expense, bank fees and other | (10) | (22) | (55) | (23) | (33) | (30) | |||||||||||||||||
Interest income | 18 | 5 | 260 | 57 | 8 | 613 | |||||||||||||||||
Income before provision for income taxes | 124 | 103 | 20 | 416 | 418 | — | |||||||||||||||||
Income taxes | 30 | 26 | 15 | 108 | 111 | (3) | |||||||||||||||||
Net income | $ | 94 | $ | 77 | 22 | % | $ | 308 | $ | 307 | — | % | |||||||||||
Cash Flow Data: | |||||||||||||||||||||||
Net cash provided by (used in) operating activities | (43) | 76 | (157) | ||||||||||||||||||||
Net cash used in investing activities | (57) | (205) | (72) | ||||||||||||||||||||
Net cash used in financing activities | (523) | (392) | 33 | ||||||||||||||||||||
Non-GAAP measures (1): | |||||||||||||||||||||||
Adjusted EBITDA | $ | 172 | 173 | (1) | $ | 557 | 577 | (3) | |||||||||||||||
Adjusted Net income | $ | 109 | 104 | 5 | $ | 365 | 378 | (3) | |||||||||||||||
Corporate Operating Cash Flows | 386 | 436 | (11) | ||||||||||||||||||||
Operating Metrics: | |||||||||||||||||||||||
Insurance Cost Ratio | 84 | % | 83 | % | 1 | % | 83 | % | 82 | % | 1 | % | |||||||||||
Average WSEs (2) | 333,286 | 351,888 | (5) | % | 329,257 | 348,833 | (6) | % | |||||||||||||||
Total WSEs (2) | 335,741 | 351,839 | (5) | % | 335,741 | 351,839 | (5) | % | |||||||||||||||
Average HRIS Users (3) | 210,863 | 247,375 | (15) | % | 219,058 | 251,707 | (13) | % | |||||||||||||||
(in millions) | September 30, 2023 | December 31, 2022 | % Change | ||||||||||||||
Balance Sheet Data: | |||||||||||||||||
Working capital | $ | 150 | $ | 338 | (56) | % | |||||||||||
Total assets | 2,966 | 3,443 | (14) | ||||||||||||||
Debt | 1,091 | 496 | 120 | ||||||||||||||
Total stockholders’ equity | 10 | 775 | (99) |
TRINET | 9 | 2023 Q3 FORM 10-Q |
MANAGEMENT'S DISCUSSION AND ANALYSIS |
TRINET | 10 | 2023 Q3 FORM 10-Q |
MANAGEMENT'S DISCUSSION AND ANALYSIS |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||
(in millions) | 2023 | 2022 | 2023 | 2022 | |||||||||||||
Net income | $ | 94 | $ | 77 | $ | 308 | $ | 307 | |||||||||
Provision for income taxes | 30 | 26 | 108 | 111 | |||||||||||||
Stock based compensation | 15 | 16 | 43 | 46 | |||||||||||||
Interest expense, bank fees and other (1) | 10 | 22 | 23 | 33 | |||||||||||||
Depreciation and amortization of intangible assets | 17 | 17 | 53 | 46 | |||||||||||||
Amortization of cloud computing arrangements | 3 | 1 | 7 | 3 | |||||||||||||
Transaction and integration costs | 3 | 14 | 15 | 31 | |||||||||||||
Adjusted EBITDA | $ | 172 | $ | 173 | $ | 557 | $ | 577 | |||||||||
Adjusted EBITDA Margin | 14.1 | % | 14.0 | % | 15.1 | % | 15.7 | % |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||
(in millions) | 2023 | 2022 | 2023 | 2022 | |||||||||||||
Net income | $ | 94 | $ | 77 | $ | 308 | $ | 307 | |||||||||
Effective income tax rate adjustment | (2) | — | 1 | 4 | |||||||||||||
Stock based compensation | 15 | 16 | 43 | 46 | |||||||||||||
Amortization of other intangible assets, net | 5 | 5 | 16 | 13 | |||||||||||||
Non-cash interest expense | — | 1 | 1 | 1 | |||||||||||||
Transaction and integration costs | 3 | 14 | 15 | 31 | |||||||||||||
Income tax impact of pre-tax adjustments | (6) | (9) | (19) | (24) | |||||||||||||
Adjusted Net Income | $ | 109 | $ | 104 | $ | 365 | $ | 378 |
Nine Months Ended September 30, | ||||||||
(in millions) | 2023 | 2022 | ||||||
Net cash provided by (used in) operating activities | $ | (43) | $ | 76 | ||||
Less: Change in WSE related other current assets | (134) | (101) | ||||||
Less: Change in WSE related liabilities | (295) | (259) | ||||||
Net cash used in operating activities - WSE | $ | (429) | $ | (360) | ||||
Net cash provided by operating activities - Corporate | $ | 386 | $ | 436 |
TRINET | 11 | 2023 Q3 FORM 10-Q |
MANAGEMENT'S DISCUSSION AND ANALYSIS |
TRINET | 12 | 2023 Q3 FORM 10-Q |
MANAGEMENT'S DISCUSSION AND ANALYSIS |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||
(in millions) | 2023 | 2022 | 2023 | 2022 | |||||||||||||
Insurance costs | $ | 874 | $ | 872 | $ | 2,594 | $ | 2,547 | |||||||||
Insurance service revenues | 1,037 | 1,052 | 3,110 | 3,094 | |||||||||||||
Insurance Cost Ratio | 84 | % | 83 | % | 83 | % | 82 | % |
TRINET | 13 | 2023 Q3 FORM 10-Q |
MANAGEMENT'S DISCUSSION AND ANALYSIS |
PSR | ||||||||||||||
ISR - % represents proportion of insurance service revenues to total revenues | ||||||||||||||
*Total revenues generated from PEO services only |
TRINET | 14 | 2023 Q3 FORM 10-Q |
MANAGEMENT'S DISCUSSION AND ANALYSIS |
(in millions) | ||||||||
$120 | Third Quarter 2022 Operating Income | |||||||
-19 | Lower total revenues primarily driven by lower average volume from our PEO services and lower health plan enrollment, partially offset by rate increases. | |||||||
-2 | Flat insurance costs as higher health cost rates were offset by lower health plan enrollment and lower volume due to lower Average WSEs. | |||||||
+17 | Lower OE primarily as a result of lower spend in consulting, facilities, and tax and licenses, partially offset by higher conference and event expenses. | |||||||
$116 | Third Quarter 2023 Operating Income |
(in millions) | ||||||||
$443 | YTD 2022 Operating Income | |||||||
+18 | Higher total revenues primarily driven by rate increases and that no reduction in revenue was recognized in 2023 related to our 2022 Credits, partially offset by lower Average WSEs. | |||||||
-47 | Higher insurance costs primarily as a result of higher health cost rates, partially offset by lower Average WSEs. | |||||||
-32 | Higher OE primarily as a result of higher compensation, S&M and technology spend to improve client experience, enhance service offerings, and improve processes, including a full nine months of supporting the HRIS product, together with higher sales and marketing expenses to support sales efforts. This was partially offset by lower spend in consulting and facilities. | |||||||
$382 | YTD 2023 Operating Income |
TRINET | 15 | 2023 Q3 FORM 10-Q |
MANAGEMENT'S DISCUSSION AND ANALYSIS |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||
(in millions) | 2023 | 2022 | 2023 | 2022 | |||||||||||||
PEO Services | $ | 168 | $ | 177 | $ | 527 | $ | 535 | |||||||||
HRIS Cloud Services | 17 | 12 | 12 | 40 | 30 | ||||||||||||
Total | $ | 185 | $ | 189 | $ | 567 | $ | 565 |
TRINET | 16 | 2023 Q3 FORM 10-Q |
MANAGEMENT'S DISCUSSION AND ANALYSIS |
TRINET | 17 | 2023 Q3 FORM 10-Q |
MANAGEMENT'S DISCUSSION AND ANALYSIS |
TRINET | 18 | 2023 Q3 FORM 10-Q |
MANAGEMENT'S DISCUSSION AND ANALYSIS |
% represents portion of compensation related expense included in operating expenses |
TRINET | 19 | 2023 Q3 FORM 10-Q |
MANAGEMENT'S DISCUSSION AND ANALYSIS |
(in millions) | ||||||||
$249 | Q3 2022 Operating Expenses | |||||||
-5 | COPS decreased, driven primarily by lower spend in tax and licenses, corporate insurance, and office expenses. | |||||||
+3 | S&M increased, driven primarily by higher conferences and events expenses and higher compensation from the growth in our sales force, partially offset by lower advertising expenses. | |||||||
-12 | G&A decreased, driven primarily by lower transaction and integration expenses as well as lower consulting, facilities and recruiting expenses. | |||||||
-3 | SD&P decreased, driven primarily by lower compensation and consulting expenses. | |||||||
— | D&A was consistent with the prior period. | |||||||
$232 | Q3 2023 Operating Expenses |
(in millions) | ||||||||
$669 | YTD 2022 Operating Expenses | |||||||
+6 | COPS increased, driven primarily by higher compensation expense to support WSEs and incremental costs related to our HRIS cloud services, partially offset by lower corporate insurance and office expenses. | |||||||
+35 | S&M increased, driven primarily by higher compensation from the growth in our sales force, higher conference and events expenses and higher broker commissions | |||||||
-11 | G&A decreased, driven primarily by transaction and integration expenses as well as lower costs in consulting, facilities and recruiting expenses. | |||||||
-5 | SD&P decreased, driven primarily by lower compensation and consulting expenses. | |||||||
+7 | D&A increased, due to the amortization of intangible assets recognized for the Zenefits and Clarus R+D acquisitions. | |||||||
$701 | YTD 2023 Operating Expenses |
TRINET | 20 | 2023 Q3 FORM 10-Q |
MANAGEMENT'S DISCUSSION AND ANALYSIS |
TRINET | 21 | 2023 Q3 FORM 10-Q |
MANAGEMENT'S DISCUSSION AND ANALYSIS |
TRINET | 22 | 2023 Q3 FORM 10-Q |
MANAGEMENT'S DISCUSSION AND ANALYSIS |
September 30, 2023 | December 31, 2022 | ||||||||||||||||||||||
(in millions) | Corporate | WSE | Total | Corporate | WSE | Total | |||||||||||||||||
Current assets: | |||||||||||||||||||||||
Cash and cash equivalents | $ | 170 | $ | — | $ | 170 | $ | 354 | $ | — | $ | 354 | |||||||||||
Investments | 75 | — | 75 | 76 | — | 76 | |||||||||||||||||
Restricted cash, cash equivalents and investments | 21 | 812 | 833 | 22 | 1,241 | 1,263 | |||||||||||||||||
Other current assets | 86 | 689 | 775 | 78 | 555 | 633 | |||||||||||||||||
Total current assets | $ | 352 | $ | 1,501 | $ | 1,853 | $ | 530 | $ | 1,796 | $ | 2,326 | |||||||||||
Total current liabilities | $ | 202 | $ | 1,501 | $ | 1,703 | $ | 192 | $ | 1,796 | $ | 1,988 | |||||||||||
Working capital | $ | 150 | $ | — | $ | 150 | $ | 338 | $ | — | $ | 338 | |||||||||||
TRINET | 23 | 2023 Q3 FORM 10-Q |
MANAGEMENT'S DISCUSSION AND ANALYSIS |
Nine Months Ended September 30, | |||||||||||||||||||||||
(in millions) | 2023 | 2022 | |||||||||||||||||||||
Corporate | WSE | Total | Corporate | WSE | Total | ||||||||||||||||||
Net cash provided by (used in): | |||||||||||||||||||||||
Operating activities | $ | 386 | $ | (429) | $ | (43) | $ | 436 | $ | (360) | $ | 76 | |||||||||||
Investing activities | (56) | (1) | (57) | (199) | (6) | (205) | |||||||||||||||||
Financing activities | (523) | — | (523) | (392) | — | (392) | |||||||||||||||||
Net decrease in cash and cash equivalents, unrestricted and restricted | $ | (193) | $ | (430) | $ | (623) | $ | (155) | $ | (366) | $ | (521) | |||||||||||
Cash and cash equivalents, unrestricted and restricted: | |||||||||||||||||||||||
Beginning of period | $ | 406 | $ | 1,131 | $ | 1,537 | $ | 660 | $ | 1,078 | $ | 1,738 | |||||||||||
End of period | $ | 213 | $ | 701 | $ | 914 | $ | 505 | $ | 712 | $ | 1,217 | |||||||||||
Net increase (decrease) in cash and cash equivalents: | |||||||||||||||||||||||
Unrestricted | $ | (184) | $ | — | $ | (184) | $ | (158) | $ | — | $ | (158) | |||||||||||
Restricted | $ | (9) | $ | (430) | $ | (439) | $ | 3 | $ | (366) | $ | (363) |
Nine Months Ended September 30, | ||||||||
(in millions) | 2023 | 2022 | ||||||
Net cash provided by (used in) operating activities | $ | (43) | $ | 76 | ||||
Net cash used in operating activities - WSE | (429) | (360) | ||||||
Net cash provided by operating activities - Corporate | 386 | 436 |
TRINET | 24 | 2023 Q3 FORM 10-Q |
MANAGEMENT'S DISCUSSION AND ANALYSIS |
Nine Months Ended September 30, | ||||||||
(in millions) | 2023 | 2022 | ||||||
Investments: | ||||||||
Purchases of investments | $ | (226) | $ | (337) | ||||
Proceeds from sale and maturity of investments | 223 | 390 | ||||||
Acquisition of subsidiaries | — | (219) | ||||||
Cash used in investments | $ | (3) | $ | (166) | ||||
Cash used in capital expenditures | $ | (54) | $ | (39) | ||||
Cash used in investing activities | $ | (57) | $ | (205) |
Nine Months Ended September 30, | ||||||||
(in millions) | 2023 | 2022 | ||||||
Financing activities | ||||||||
Repurchase of common stock, net of issuance costs | (1,114) | (392) | ||||||
Proceeds from issuance of 2031 Notes | 400 | — | ||||||
Payment of long-term financing fees and debt issuance costs | (9) | — | ||||||
Proceeds from revolving credit agreement borrowings | 695 | — | ||||||
Repayment of borrowings under revolving credit facility | (495) | |||||||
Cash used in financing activities | $ | (523) | $ | (392) |
TRINET | 25 | 2023 Q3 FORM 10-Q |
MANAGEMENT'S DISCUSSION AND ANALYSIS |
TRINET | 26 | 2023 Q3 FORM 10-Q |
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK AND CONTROLS AND PROCEDURES |
TRINET | 27 | 2023 Q3 FORM 10-Q |
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK AND CONTROLS AND PROCEDURES |
TRINET | 28 | 2023 Q3 FORM 10-Q |
FINANCIAL STATEMENTS |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||
(in millions except per share data) | 2023 | 2022 | 2023 | 2022 | |||||||||||||
Professional service revenues | $ | 185 | $ | 189 | $ | 567 | $ | 565 | |||||||||
Insurance service revenues | 1,037 | 1,052 | 3,110 | 3,094 | |||||||||||||
Total revenues | 1,222 | 1,241 | 3,677 | 3,659 | |||||||||||||
Insurance costs | 874 | 872 | 2,594 | 2,547 | |||||||||||||
Cost of providing services | 74 | 79 | 231 | 225 | |||||||||||||
Sales and marketing | 75 | 72 | 214 | 179 | |||||||||||||
General and administrative | 51 | 63 | 154 | 165 | |||||||||||||
Systems development and programming | 15 | 18 | 49 | 54 | |||||||||||||
Depreciation and amortization of intangible assets | 17 | 17 | 53 | 46 | |||||||||||||
Total costs and operating expenses | 1,106 | 1,121 | 3,295 | 3,216 | |||||||||||||
Operating income | 116 | 120 | 382 | 443 | |||||||||||||
Other income (expense): | |||||||||||||||||
Interest expense, bank fees and other | (10) | (22) | (23) | (33) | |||||||||||||
Interest income | 18 | 5 | 57 | 8 | |||||||||||||
Income before provision for income taxes | 124 | 103 | 416 | 418 | |||||||||||||
Income taxes | 30 | 26 | 108 | 111 | |||||||||||||
Net income | $ | 94 | $ | 77 | $ | 308 | $ | 307 | |||||||||
Other comprehensive income (loss), net of income taxes | (2) | 7 | (3) | (4) | |||||||||||||
Comprehensive income | $ | 92 | $ | 84 | $ | 305 | $ | 303 | |||||||||
Net income per share: | |||||||||||||||||
Basic | $ | 1.65 | $ | 1.23 | $ | 5.23 | $ | 4.85 | |||||||||
Diluted | $ | 1.63 | $ | 1.22 | $ | 5.20 | $ | 4.81 | |||||||||
Weighted average shares: | |||||||||||||||||
Basic | 57 | 62 | 59 | 63 | |||||||||||||
Diluted | 58 | 63 | 59 | 64 |
TRINET | 29 | 2023 Q3 FORM 10-Q |
FINANCIAL STATEMENTS |
September 30, | December 31, | |||||||||||||
(in millions, except share and per share data) | 2023 | 2022 | ||||||||||||
ASSETS | ||||||||||||||
Current assets: | ||||||||||||||
Cash and cash equivalents | $ | 170 | $ | 354 | ||||||||||
Investments | 75 | 76 | ||||||||||||
Restricted cash, cash equivalents and investments | 833 | 1,263 | ||||||||||||
Accounts receivable, net | 21 | 19 | ||||||||||||
Unbilled revenue, net | 404 | 375 | ||||||||||||
Prepaid expenses, net | 75 | 71 | ||||||||||||
Other payroll assets | 226 | 122 | ||||||||||||
Other current assets | 49 | 46 | ||||||||||||
Total current assets | 1,853 | 2,326 | ||||||||||||
Restricted cash, cash equivalents and investments, noncurrent | 154 | 153 | ||||||||||||
Investments, noncurrent | 143 | 151 | ||||||||||||
Property and equipment, net | 16 | 24 | ||||||||||||
Operating lease right-of-use asset | 24 | 31 | ||||||||||||
Goodwill | 462 | 462 | ||||||||||||
Software and other intangible assets, net | 169 | 163 | ||||||||||||
Other assets | 145 | 133 | ||||||||||||
Total assets | $ | 2,966 | $ | 3,443 | ||||||||||
Liabilities and stockholders' equity | ||||||||||||||
Current liabilities: | ||||||||||||||
Accounts payable and other current liabilities | $ | 109 | $ | 98 | ||||||||||
Client deposits and other client liabilities | 73 | 106 | ||||||||||||
Accrued wages | 458 | 437 | ||||||||||||
Accrued health insurance costs, net | 183 | 174 | ||||||||||||
Accrued workers' compensation costs, net | 51 | 54 | ||||||||||||
Payroll tax liabilities and other payroll withholdings | 804 | 1,087 | ||||||||||||
Operating lease liabilities | 15 | 15 | ||||||||||||
Insurance premiums and other payables | 10 | 17 | ||||||||||||
Total current liabilities | 1,703 | 1,988 | ||||||||||||
Long-term debt, noncurrent | 1,091 | 496 | ||||||||||||
Accrued workers' compensation costs, noncurrent, net | 122 | 128 | ||||||||||||
Deferred taxes | 5 | 8 | ||||||||||||
Operating lease liabilities, noncurrent | 30 | 41 | ||||||||||||
Other non-current liabilities | 5 | 7 | ||||||||||||
Total liabilities | 2,956 | 2,668 | ||||||||||||
Stockholders' equity: | ||||||||||||||
Preferred stock | — | — | ||||||||||||
($0.000025 par value per share; 20,000,000 shares authorized; no shares issued or outstanding at September 30, 2023 and December 31, 2022) | ||||||||||||||
Common stock and additional paid-in capital | 953 | 899 | ||||||||||||
($0.000025 par value per share; 750,000,000 shares authorized; 50,507,590 and 60,555,661 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively) | ||||||||||||||
Accumulated deficit | (935) | (119) | ||||||||||||
Accumulated other comprehensive loss | (8) | (5) | ||||||||||||
Total stockholders' equity | 10 | 775 | ||||||||||||
Total liabilities & stockholders' equity | $ | 2,966 | $ | 3,443 |
TRINET | 30 | 2023 Q3 FORM 10-Q |
FINANCIAL STATEMENTS |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||
(in millions) | 2023 | 2022 | 2023 | 2022 | |||||||||||||
Total Stockholders' Equity, beginning balance | $ | 915 | $ | 763 | $ | 775 | $ | 881 | |||||||||
Common Stock and Additional Paid-In Capital | |||||||||||||||||
Beginning balance | 934 | 861 | 899 | 808 | |||||||||||||
Issuance of common stock from exercise of stock options | 3 | — | 3 | 1 | |||||||||||||
Issuance of common stock for employee stock purchase plan | — | — | 6 | 5 | |||||||||||||
Issuance of common stock for the acquisition of Zenefits | — | — | — | 17 | |||||||||||||
Stock based compensation expense | 16 | 17 | 45 | 47 | |||||||||||||
Ending balance | 953 | 878 | 953 | 878 | |||||||||||||
Retained Earnings (Accumulated Deficit) | |||||||||||||||||
Beginning balance | (13) | (86) | (120) | 74 | |||||||||||||
Net income | 94 | 77 | 308 | 307 | |||||||||||||
Repurchase of common stock | (1,004) | (1) | (1,102) | (383) | |||||||||||||
Stock repurchase excise tax | (7) | — | (7) | — | |||||||||||||
Awards effectively repurchased for required employee withholding taxes | (5) | (7) | (14) | (15) | |||||||||||||
Ending balance | (935) | (17) | (935) | (17) | |||||||||||||
Accumulated Other Comprehensive Income | |||||||||||||||||
Beginning balance | (6) | (12) | (5) | (1) | |||||||||||||
Other comprehensive income (loss) | (2) | 7 | (3) | (4) | |||||||||||||
Ending balance | (8) | (5) | (8) | (5) | |||||||||||||
Total Stockholders' Equity, ending balance | $ | 10 | $ | 856 | $ | 10 | $ | 856 | |||||||||
TRINET | 31 | 2023 Q3 FORM 10-Q |
FINANCIAL STATEMENTS |
Nine Months Ended September 30, | ||||||||
(in millions) | 2023 | 2022 | ||||||
Operating activities | ||||||||
Net income | $ | 308 | $ | 307 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Depreciation and amortization of intangible assets | 53 | 48 | ||||||
Amortization of deferred costs | 31 | 26 | ||||||
Amortization of ROU asset, lease modification, impairment, and abandonment | 5 | 15 | ||||||
Stock based compensation | 43 | 46 | ||||||
Deferred income taxes | (2) | 1 | ||||||
Provision for doubtful accounts | 2 | 1 | ||||||
Losses and impairment on investments | — | 18 | ||||||
Losses from disposition of assets | — | 3 | ||||||
Other | 1 | — | ||||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | (4) | 10 | ||||||
Unbilled revenue, net | (29) | (38) | ||||||
Prepaid expenses, net | (4) | 3 | ||||||
Other assets | (44) | (30) | ||||||
Other payroll assets | (104) | (56) | ||||||
Accounts payable and other liabilities | 9 | 5 | ||||||
Client deposits and other client liabilities | (33) | (43) | ||||||
Accrued wages | 21 | 40 | ||||||
Accrued health insurance costs, net | 9 | (10) | ||||||
Accrued workers' compensation costs, net | (9) | (5) | ||||||
Payroll taxes payable and other payroll withholdings | (283) | (252) | ||||||
Operating lease liabilities | (13) | (13) | ||||||
Net cash provided by (used in) operating activities | (43) | 76 | ||||||
Investing activities | ||||||||
Purchases of marketable securities | (226) | (337) | ||||||
Proceeds from sale and maturity of marketable securities | 223 | 390 | ||||||
Acquisitions of property and equipment | (54) | (39) | ||||||
Acquisition of subsidiary, net of cash acquired | — | (219) | ||||||
Net cash used in investing activities | (57) | (205) | ||||||
Financing activities | ||||||||
Repurchase of common stock | (1,109) | (383) | ||||||
Proceeds from issuance of common stock | 9 | 6 | ||||||
Proceeds from issuance of 2031 Notes | 400 | — | ||||||
Awards effectively repurchased for required employee withholding taxes | (14) | (15) | ||||||
Proceeds from revolving credit agreement borrowings | 695 | — | ||||||
Payment of long-term financing fees and debt issuance costs | (9) | — | ||||||
Repayment of borrowings under revolving credit facility | (495) | — | ||||||
Net cash used in financing activities | (523) | (392) | ||||||
Net decrease in cash and cash equivalents, unrestricted and restricted | (623) | (521) | ||||||
Cash and cash equivalents, unrestricted and restricted: | ||||||||
Beginning of period | 1,537 | 1,738 | ||||||
End of period | $ | 914 | $ | 1,217 | ||||
Supplemental disclosures of cash flow information | ||||||||
Interest paid | $ | 21 | $ | 18 | ||||
Income taxes paid, net | $ | 89 | $ | 60 | ||||
Supplemental schedule of noncash investing and financing activities | ||||||||
Payable for purchase of property and equipment | $ | 2 | $ | 7 | ||||
Acquisitions of subsidiaries paid in stock | $ | — | $ | 4 |
TRINET | 32 | 2023 Q3 FORM 10-Q |
FINANCIAL STATEMENTS |
TRINET | 33 | 2023 Q3 FORM 10-Q |
FINANCIAL STATEMENTS |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||
(in millions) | 2023 | 2022 | 2023 | 2022 | |||||||||||||
Balance at beginning of period | $ | 50 | $ | 26 | $ | 75 | $ | 48 | |||||||||
(+) Accruals | — | — | — | 25 | |||||||||||||
(-) Distributions to clients | (8) | (1) | (33) | (48) | |||||||||||||
Balance at end of period | $ | 42 | $ | 25 | $ | 42 | $ | 25 |
TRINET | 34 | 2023 Q3 FORM 10-Q |
FINANCIAL STATEMENTS |
TRINET | 35 | 2023 Q3 FORM 10-Q |
FINANCIAL STATEMENTS |
September 30, 2023 | December 31, 2022 | ||||||||||||||||||||||
(in millions) | Cash and cash equivalents | Available-for-sale marketable securities | Total | Cash and cash equivalents | Available-for-sale marketable securities | Total | |||||||||||||||||
Cash and cash equivalents | $ | 170 | $ | — | $ | 170 | $ | 354 | $ | — | $ | 354 | |||||||||||
Investments | — | 75 | 75 | — | 76 | 76 | |||||||||||||||||
Restricted cash, cash equivalents and investments: | |||||||||||||||||||||||
Payroll funds collected | 635 | — | 635 | 1,062 | — | 1,062 | |||||||||||||||||
Collateral for health benefits claims | 31 | 110 | 141 | 29 | 110 | 139 | |||||||||||||||||
Collateral for workers' compensation claims | 55 | — | 55 | 58 | — | 58 | |||||||||||||||||
Other security deposits | 2 | — | 2 | 4 | — | 4 | |||||||||||||||||
Total restricted cash, cash equivalents and investments | 723 | 110 | 833 | 1,153 | 110 | 1,263 | |||||||||||||||||
Investments, noncurrent | — | 143 | 143 | — | 151 | 151 | |||||||||||||||||
Restricted cash, cash equivalents and investments, noncurrent | |||||||||||||||||||||||
Collateral for workers' compensation claims | 21 | 133 | 154 | 27 | 123 | 150 | |||||||||||||||||
Other security deposits | — | — | 3 | — | 3 | ||||||||||||||||||
Total | $ | 914 | $ | 461 | $ | 1,375 | $ | 1,537 | $ | 460 | $ | 1,997 |
TRINET | 36 | 2023 Q3 FORM 10-Q |
FINANCIAL STATEMENTS |
(in millions) | Fair Value Level | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Cash and Cash Equivalents | Investments | Restricted Cash, Cash Equivalents and Investments | ||||||||||||||||||
September 30, 2023 | ||||||||||||||||||||||||||
Cash equivalents: | ||||||||||||||||||||||||||
Money market mutual funds | Level 1 | $ | 134 | $ | — | $ | — | $ | 134 | $ | 47 | $ | — | $ | 87 | |||||||||||
U.S. treasuries | Level 2 | 4 | — | — | 4 | 4 | — | — | ||||||||||||||||||
Total cash equivalents | 138 | — | — | 138 | 51 | — | 87 | |||||||||||||||||||
AFS Investments: | ||||||||||||||||||||||||||
Asset-backed securities | Level 2 | 45 | — | (1) | 44 | — | 44 | — | ||||||||||||||||||
Corporate bonds | Level 2 | 131 | — | (1) | 130 | — | 102 | 28 | ||||||||||||||||||
Agency securities | Level 2 | 40 | — | (1) | 39 | — | 11 | 28 | ||||||||||||||||||
U.S. treasuries | Level 2 | 241 | — | (5) | 236 | — | 57 | 179 | ||||||||||||||||||
Certificate of deposit | Level 2 | 7 | — | — | 7 | — | — | 7 | ||||||||||||||||||
Other debt securities | Level 2 | 5 | — | — | 5 | — | 5 | — | ||||||||||||||||||
Total AFS Investments | $ | 469 | $ | — | $ | (8) | $ | 461 | $ | — | $ | 219 | $ | 242 |
(in millions) | Fair Value Level | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Cash and Cash Equivalents | Investments | Restricted Cash, Cash Equivalents and Investments | ||||||||||||||||||
December 31, 2022 | ||||||||||||||||||||||||||
Cash equivalents: | ||||||||||||||||||||||||||
Money market mutual funds | Level 1 | $ | 314 | $ | — | $ | — | $ | 314 | $ | 225 | $ | — | $ | 89 | |||||||||||
U.S. treasuries | Level 2 | 18 | — | — | 18 | 18 | — | — | ||||||||||||||||||
Total cash equivalents | 332 | — | — | 332 | 243 | — | 89 | |||||||||||||||||||
AFS Investments: | ||||||||||||||||||||||||||
Asset-backed securities | Level 2 | 42 | — | (2) | 40 | — | 40 | — | ||||||||||||||||||
Corporate bonds | Level 2 | 140 | — | (1) | 139 | — | 112 | 27 | ||||||||||||||||||
Agency securities | Level 2 | 33 | — | (1) | 32 | — | 5 | 27 | ||||||||||||||||||
U.S. treasuries | Level 2 | 229 | — | — | 229 | — | 62 | 167 | ||||||||||||||||||
Certificate of deposit | Level 2 | 12 | — | — | 12 | — | — | 12 | ||||||||||||||||||
Other debt securities | Level 2 | 8 | — | — | 8 | — | 7 | 1 | ||||||||||||||||||
Total AFS Investments | $ | 464 | $ | — | $ | (4) | $ | 460 | $ | — | $ | 226 | $ | 234 |
TRINET | 37 | 2023 Q3 FORM 10-Q |
FINANCIAL STATEMENTS |
(in millions) | September 30, 2023 | ||||||||||
One year or less | $ | 117 | |||||||||
Over one year through five years | 312 | ||||||||||
Over five years through ten years | 12 | ||||||||||
Over ten years | 20 | ||||||||||
Total fair value | $ | 461 |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||
(in millions) | 2023 | 2022 | 2023 | 2022 | |||||||||||||
Gross proceeds from sales | $ | 31 | $ | 177 | $ | 115 | $ | 219 | |||||||||
Gross proceeds from maturities | 19 | 49 | 108 | 181 | |||||||||||||
Total | $ | 50 | $ | 226 | $ | 223 | $ | 400 |
TRINET | 38 | 2023 Q3 FORM 10-Q |
FINANCIAL STATEMENTS |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||
(in millions) | 2023 | 2022 | 2023 | 2022 | |||||||||||||
Total accrued costs, beginning of period | $ | 178 | $ | 189 | $ | 189 | $ | 198 | |||||||||
Incurred | |||||||||||||||||
Current year | 13 | 18 | 47 | 51 | |||||||||||||
Prior years | (2) | (3) | (25) | (23) | |||||||||||||
Total incurred | 11 | 15 | 22 | 28 | |||||||||||||
Paid | |||||||||||||||||
Current year | (4) | (4) | (6) | (6) | |||||||||||||
Prior years | (7) | (8) | (27) | (28) | |||||||||||||
Total paid | (11) | (12) | (33) | (34) | |||||||||||||
Total accrued costs, end of period | $ | 178 | $ | 192 | $ | 178 | $ | 192 |
(in millions) | September 30, 2023 | December 31, 2022 | ||||||
Total accrued costs, end of period | $ | 178 | $ | 189 | ||||
Collateral paid to carriers and offset against accrued costs | (5) | (7) | ||||||
Total accrued costs, net of carrier collateral offset | $ | 173 | $ | 182 | ||||
Payable in less than 1 year (net of collateral paid to carriers of $1 and $2 at September 30, 2023 and December 31, 2022, respectively) | $ | 51 | $ | 54 | ||||
Payable in more than 1 year (net of collateral paid to carriers of $4 and $5 at September 30, 2023 and December 31, 2022, respectively) | 122 | 128 | ||||||
Total accrued costs, net of carrier collateral offset | $ | 173 | $ | 182 | ||||
TRINET | 39 | 2023 Q3 FORM 10-Q |
FINANCIAL STATEMENTS |
(Dollars in millions) | Annual contractual interest rate | Effective interest rate | Principal amount | Deferred issuance costs | Less: current portion | Long-term debt, noncurrent | |||||||||||||||||
September 30, 2023 | December 31, 2022 | ||||||||||||||||||||||
2029 Notes | 3.50 | % | 3.67 | % | $ | 500 | $ | (4) | $ | — | $ | 496 | $ | 496 | |||||||||
2031 Notes | 7.125 | % | 7.290 | % | $ | 400 | $ | (5) | $ | — | $ | 395 | $ | — |
TRINET | 40 | 2023 Q3 FORM 10-Q |
FINANCIAL STATEMENTS |
TRINET | 41 | 2023 Q3 FORM 10-Q |
FINANCIAL STATEMENTS |
Total Number of RSUs | Total Number of Shares | Weighted-Average Grant Date Fair Value | |||||||||
Nonvested at December 31, 2022 | 1,198,561 | 1,198,561 | $ | 80.75 | |||||||
Granted | 755,789 | 755,789 | 77.56 | ||||||||
Vested | (464,051) | (464,051) | 76.36 | ||||||||
Forfeited | (89,029) | (89,029) | 82.57 | ||||||||
Nonvested at September 30, 2023 | 1,401,270 | 1,401,270 | $ | 80.02 |
Total Number of RSUs | Total Number of Shares | Weighted-Average Grant Date Fair Value | |||||||||
Nonvested at December 31, 2022 | 202,586 | 202,586 | $ | 86.82 | |||||||
Granted | 177,067 | 177,067 | 79.05 | ||||||||
Nonvested at September 30, 2023 | 379,653 | 379,653 | $ | 83.20 |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||
(in millions) | 2023 | 2022 | 2023 | 2022 | |||||||||||||
Cost of providing services | $ | 3 | $ | 3 | $ | 10 | $ | 10 | |||||||||
Sales and marketing | 2 | 2 | 6 | 5 | |||||||||||||
General and administrative | 9 | 9 | 24 | 28 | |||||||||||||
Systems development and programming costs | 1 | 2 | 3 | 3 | |||||||||||||
Total stock based compensation expense | $ | 15 | $ | 16 | $ | 43 | $ | 46 | |||||||||
Total stock based compensation capitalized | $ | 1 | $ | — | $ | 2 | $ | 1 | |||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||
Shares issued and outstanding, beginning balance | 59,674,960 | 62,087,303 | 60,555,661 | 65,968,224 | |||||||||||||
Issuance of common stock from vested restricted stock units | 161,125 | 199,171 | 464,051 | 496,051 | |||||||||||||
Issuance of common stock from exercise of stock options | 73,818 | 21,750 | 155,485 | 94,139 | |||||||||||||
Issuance of common stock for employee stock purchase plan | — | — | 104,017 | 73,808 | |||||||||||||
Issuance of common stock for the acquisition of Zenefits | — | — | — | 193,221 | |||||||||||||
Repurchase of common stock | (9,345,794) | — | (10,611,683) | (4,419,423) | |||||||||||||
Awards effectively repurchased for required employee withholding taxes | (56,519) | (78,718) | (159,941) | (176,514) | |||||||||||||
Shares issued and outstanding, ending balance | 50,507,590 | 62,229,506 | 50,507,590 | 62,229,506 |
TRINET | 42 | 2023 Q3 FORM 10-Q |
FINANCIAL STATEMENTS |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||
(in millions, except per share data) | 2023 | 2022 | 2023 | 2022 | |||||||||||||
Net income | $ | 94 | $ | 77 | $ | 308 | $ | 307 | |||||||||
Weighted average shares of common stock outstanding | 57 | 62 | 59 | 63 | |||||||||||||
Basic EPS | $ | 1.65 | $ | 1.23 | $ | 5.23 | $ | 4.85 | |||||||||
Net income | $ | 94 | $ | 77 | $ | 308 | $ | 307 | |||||||||
Weighted average shares of common stock outstanding | 57 | 62 | 59 | 63 | |||||||||||||
Dilutive effect of stock options and restricted stock units | 1 | 1 | — | 1 | |||||||||||||
Weighted average shares of common stock outstanding | 58 | 63 | 59 | 64 | |||||||||||||
Diluted EPS | $ | 1.63 | $ | 1.22 | $ | 5.20 | $ | 4.81 | |||||||||
Common stock equivalents excluded from income per diluted share because of their anti-dilutive effect | — | 1 | 1 | 1 |
TRINET | 43 | 2023 Q3 FORM 10-Q |
OTHER INFORMATION |
Period | Total Number of Shares Purchased (1) (2) | Weighted Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans | Approximate Dollar Value ($ millions) of Shares that May Yet be Purchased Under the Plans (3) | |||||||||||||||||||
July 1 - July 31, 2023 | 2,697 | $ | 95.20 | — | $ | 1,446 | |||||||||||||||||
August 1 - August 31, 2023 | 6,034,609 | $ | 107.00 | 5,981,308 | $ | 806 | |||||||||||||||||
September 1 - September 30, 2023 | 3,365,007 | $ | 107.00 | 3,364,486 | $ | 446 | |||||||||||||||||
Total | 9,402,313 | 9,345,794 |
TRINET | 44 | 2023 Q3 FORM 10-Q |
OTHER INFORMATION |
TRINET | 45 | 2023 Q3 FORM 10-Q |
EXHIBITS |
Incorporated by Reference | ||||||||||||||||||||||||||||||||||||||
Exhibit No. | Exhibit | Form | File No. | Exhibit | Filing Date | Filed Herewith | ||||||||||||||||||||||||||||||||
3.1 | 8-K | 001-36373 | 3.1 | 5/30/2023 | ||||||||||||||||||||||||||||||||||
3.2 | 8-K | 001-36373 | 3.1 | 3/27/2023 | ||||||||||||||||||||||||||||||||||
4.1 | 8-K | 001-36373 | 4.1 | 2/2/2017 | ||||||||||||||||||||||||||||||||||
4.2 | 8-K | 001-36373 | 4.1 | 8/16/2023 | ||||||||||||||||||||||||||||||||||
4.3 | X | |||||||||||||||||||||||||||||||||||||
10.1 | 8-K | 001-36373 | 10.1 | 8/16/2023 | ||||||||||||||||||||||||||||||||||
10.2 | 8-K | 001-36373 | 10.1 | 7/31/2023 | ||||||||||||||||||||||||||||||||||
31.1 | X | |||||||||||||||||||||||||||||||||||||
31.2 | X | |||||||||||||||||||||||||||||||||||||
32.1* | X | |||||||||||||||||||||||||||||||||||||
101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | |||||||||||||||||||||||||||||||||||||
101.SCH | XBRL Taxonomy Extension Schema Linkbase Document | |||||||||||||||||||||||||||||||||||||
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | |||||||||||||||||||||||||||||||||||||
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | |||||||||||||||||||||||||||||||||||||
101.LAB | XBRL Taxonomy Extension Label Linkbase Document | |||||||||||||||||||||||||||||||||||||
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document | |||||||||||||||||||||||||||||||||||||
104 | Cover Page Interactive Data File (embedded with the Inline XBRL document) |
* | Document has been furnished, is deemed not filed and is not to be incorporated by reference into any of TriNet Group, Inc.’s filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, irrespective of any general incorporation language contained in any such filing. |
TRINET | 46 | 2023 Q3 FORM 10-Q |
SIGNATURES |
TRINET GROUP, INC. | |||||||||||
Date: October 25, 2023 | By: | /s/ Burton M. Goldfield | |||||||||
Burton M. Goldfield | |||||||||||
Chief Executive Officer | |||||||||||
Date: October 25, 2023 | By: | /s/ Kelly Tuminelli | |||||||||
Kelly Tuminelli | |||||||||||
Chief Financial Officer | |||||||||||
TRINET | 47 | 2023 Q3 FORM 10-Q |
CLARUS R&D SOLUTIONS, LLC | |||||
By: /s/ Alex Warren | |||||
Name: Alex Warren | |||||
Title: Chief Executive Officer and President |
MANAGEYOURPEOPLE, LLC | |||||
By: /s/ Thomas Rose | |||||
Name: Thomas Rose | |||||
Title: Chief Executive Officer and President |
PAYYOURPEOPLE, LLC | |||||
By: /s/ Thomas Rose | |||||
Name: Thomas Rose | |||||
Title: Chief Executive Officer and President |
TRINET HR III-B, INC. | |||||
By: /s/ Burton M. Goldfield | |||||
Name: Burton M. Goldfield | |||||
Title: Chief Executive Officer and President |
TRINET HR II-A, INC. | |||||
By: /s/ Alex Warren | |||||
Name: Alex Warren | |||||
Title: Chief Executive Officer and President |
TRINET HR HR X, INC. | |||||
By: /s/ Alex Warren | |||||
Name: Alex Warren | |||||
Title: Chief Executive Officer and President |
TRINET HR HR XI, INC. | |||||
By: /s/ Alex Warren | |||||
Name: Alex Warren | |||||
Title: Chief Executive Officer and President |
YOURPEOPLE, INC. | |||||
By: /s/ Thomas Rose | |||||
Name: Thomas Rose | |||||
Title: Chief Executive Officer and President |
U.S. BANK TRUST COMPANY, | |||||
NATIONAL ASSOCIATION, as Trustee | |||||
By: /s/ David Jason | |||||
Name: David Jason | |||||
Title: Vice President |
Date: October 25, 2023 | ||
/s/ Burton M. Goldfield | ||
Burton M. Goldfield | ||
President and Chief Executive Officer |
Date: October 25, 2023 | ||
/s/ Kelly Tuminelli | ||
Kelly Tuminelli | ||
Chief Financial Officer |
Date: October 25, 2023 | /s/ Burton M. Goldfield | ||||
Burton M. Goldfield | |||||
Chief Executive Officer | |||||
Date: October 25, 2023 | /s/ Kelly Tuminelli | ||||
Kelly Tuminelli | |||||
Chief Financial Officer |